Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer - Mackey, John R.; Ramos-Vazquez, Manuel; Oleg Lipatov; McCarthy, Nicole; Krasnozhon, Dmitriy; Semiglazov, Vladimir; Manikhas, Alexey; Gelmon, Karen A.; Konecny, Gottfried E.; Webster, Marc; Hegg, Roberto; Verma, Sunil; et al. (Journal of Clinical Oncology, 2015)